Behavioral and Metabolome Differences between C57BL/6 and DBA/2 Mouse Strains: Implications for Their Use as Models for Depression- and Anxiety-Like Phenotypes.
C57BL/6
DBA/2
anxiety
depression
metabolomics
psychiatry
Journal
Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790
Informations de publication
Date de publication:
23 Feb 2021
23 Feb 2021
Historique:
received:
12
12
2020
revised:
22
01
2021
accepted:
04
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
7
3
2021
Statut:
epublish
Résumé
Mouse models are widely used to study behavioral phenotypes related to neuropsychiatric disorders. However, different mouse strains vary in their inherent behavioral and molecular characteristics, which needs to be taken into account depending on the nature of the study. Here, we performed a detailed behavioral and molecular comparison of C57BL/6 (B6) and DBA/2 (DBA) mice, two inbred strains commonly used in neuropsychiatric research. We analyzed anxiety-related and depression-like traits, quantified hippocampal and plasma metabolite profiles, and assessed total antioxidant capacity (ΤAC). B6 mice exhibit increased depression-like and decreased anxiety-related behavior compared to DBA mice. Metabolite level differences indicate alterations in amino acid, nucleotide and mitochondrial metabolism that are accompanied by a decreased TAC in B6 compared to DBA mice. Our data reveal multiple behavioral and molecular differences between B6 and DBA mouse strains, which should be considered in the experimental design for phenotype, pharmacological and mechanistic studies relevant for neuropsychiatric disorders.
Identifiants
pubmed: 33672326
pii: metabo11020128
doi: 10.3390/metabo11020128
pmc: PMC7926853
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : FI-1895-1/1
Organisme : Hellenic Foundation for Research and Innovation
ID : 660
Références
Biol Psychiatry. 2011 Dec 1;70(11):1074-82
pubmed: 21791337
Sci Rep. 2016 Oct 12;6:35317
pubmed: 27731396
Neuropsychopharmacology. 2007 Jul;32(7):1452-61
pubmed: 17164812
Front Neuroendocrinol. 2018 Apr;49:72-85
pubmed: 29339091
Metab Brain Dis. 2020 Aug;35(6):979-990
pubmed: 32440806
PLoS One. 2009 Nov 13;4(11):e7821
pubmed: 19915716
Cereb Cortex. 2017 Apr 1;27(4):2580-2591
pubmed: 27073221
Trends Neurosci. 2019 Sep;42(9):573-588
pubmed: 31362874
Neuropsychopharmacology. 2016 Jan;41(1):3-23
pubmed: 26076834
Elife. 2020 Jan 10;9:
pubmed: 31922486
Mol Cell Proteomics. 2011 Dec;10(12):M111.008110
pubmed: 21862759
Behav Genet. 2013 Jan;43(1):34-50
pubmed: 23288504
Sci Rep. 2020 Oct 8;10(1):16822
pubmed: 33033336
Curr Pharm Des. 2020;26(12):1277-1285
pubmed: 32048954
PeerJ. 2018 Jul 31;6:e5309
pubmed: 30083453
Eur J Neurosci. 2020 Nov 23;:
pubmed: 33226682
R Soc Open Sci. 2019 Jun 12;6(6):190574
pubmed: 31312505
Nat Protoc. 2012 Apr 12;7(5):872-81
pubmed: 22498707
Psychopharmacology (Berl). 2000 Feb;148(2):164-70
pubmed: 10663431
J Psychiatr Res. 2012 Oct;46(10):1359-65
pubmed: 22884423
PLoS Genet. 2019 Sep 26;15(9):e1008358
pubmed: 31557158
J Psychiatr Res. 2014 Nov;58:115-22
pubmed: 25124548
Neuropsychopharmacology. 2016 Jun;41(7):1751-8
pubmed: 26567514
Amino Acids. 2012 Jun;42(6):2223-32
pubmed: 21691752
Genes Brain Behav. 2002 May;1(2):96-110
pubmed: 12884980
Nucleic Acids Res. 2018 Jul 2;46(W1):W486-W494
pubmed: 29762782
Genes Brain Behav. 2005 Jun;4(4):240-52
pubmed: 15924556
Eur J Neurosci. 2003 Jan;17(1):128-36
pubmed: 12534976
Front Neurosci. 2019 Aug 23;13:833
pubmed: 31507354
J Neurosci Res. 2009 Dec;87(16):3649-57
pubmed: 19533737
Eur J Pharmacol. 2008 Sep 11;592(1-3):116-22
pubmed: 18655786
Metabolites. 2020 Feb 17;10(2):
pubmed: 32079262
Front Psychiatry. 2018 Nov 19;9:552
pubmed: 30510519
Neuropsychopharmacology. 2013 May;38(6):1060-7
pubmed: 23303071
Sci Rep. 2017 Nov 17;7(1):15788
pubmed: 29150633